查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1969142

内视镜治疗设备市场：依产品类型、技术、应用、最终用户和通路划分－2026-2032年全球预测

Endotherapy Devices Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，内视镜治疗设备市场价值将达到 58 亿美元，到 2026 年将成长至 62 亿美元，到 2032 年将达到 99.2 亿美元，复合年增长率为 7.96%。

主要市场统计数据
基准年 2025 58亿美元
预计年份：2026年 62亿美元
预测年份 2032 99.2亿美元
复合年增长率 (%) 7.96%

内视镜治疗设备全面介绍：聚焦临床发展、技术整合、安全重点与商业性驱动因素，重塑其应用

在光学、材料科学和手术操作技术的整合发展推动下，内视镜治疗设备正迅速进入临床和商业性化的成熟阶段。临床医生日益需要能够提供更佳视野、同时降低手术风险和缩短手术时间的工具，製造商也积极响应，推出了一系列创新产品，包括一次性平台、增强型成像模式和模组化服务交付模式。因此，采购团队和临床负责人正在重新评估关于设备生命週期、整体拥有成本和感染控制等方面的传统观念。

对推动内视镜治疗未来发展的变革性转变进行分析：一次性产品的普及、影像技术的进步、人工智慧的应用以及监管转折点。

内视镜治疗设备的格局正在经历一场根本性的变革，远不止于产品本身的改进。一次性、柔软性及刚性内视镜设备正在革新采购和感染控制模式，减轻再处理负担，并改变服务经济模式。同时，高清成像和窄频成像等成像技术的创新提高了病灶检测和治疗的临床标准，促使临床医生更倾向于选择集成先进光学元件和改进照明的设备。

评估美国在 2025 年实施的关税措施对供应链、采购决策和产品设计奖励的累积影响。

2025年实施的关税措施的累积影响已对整个内视镜治疗设备生态系统产生了即时和间接的影响。短期来看，进口关税的提高推高了设备及其关键零件的到岸成本，迫使采购团队重新评估其供应商组合併探索替代筹资策略。随着相关人员将供应链韧性和可预测的前置作业时间置于优先地位，这种压力正在加速对本地生产和近岸外包的兴趣。

深入了解策略性细分，解释产品、应用、最终用户、通路和成像技术的差异如何影响临床重点和商业化策略。

市场细分洞察揭示了产品、应用、终端用户、分销管道和技术方面的差异如何影响策略重点和创新路径。以产品类型为基础的市场结构包括软式内视镜内视镜、硬式内视镜内视镜和胶囊内视镜。软式内视镜进一步分为可重复使用软式内视镜和一次性软式内视镜，而硬式内视镜则分为可重复使用硬式内视镜和一次性硬式内视镜。这种产品层面的细分会影响消毒通讯协定、设备人体工学设计和服务模式的决策，也是企业决定投资一次性器械还是耐用器械的重要因素。

各区域的关键见解：美洲、欧洲、中东和非洲以及亚太地区对采用趋势、监管应对措施和製造策略的影响。

在全球内视镜治疗领域，区域趋势持续影响技术应用模式、监管合作和生产策略。在美洲，完善的采购流程和对感染控制的高度重视推动了对一次性医疗器材和先进影像工具的需求。同时，区域创新中心正在支持临床试验和上市后证据的收集。健保报销机制和医院整合趋势正在影响新技术快速融入手术流程，而大规模医疗系统作为早期采用者已证实可改善治疗效果的技术的机构，发挥关键作用。

主要企业层级深入了解现有企业和新参与企业如何利用产品组合扩张、伙伴关係和证据产生来确保临床准入和商业性优势。

创新、服务经济和策略联盟的互动正在重塑主要企业之间的竞争动态。成熟的医疗设备製造商正在其产品组合中增加一次性产品、先进的成像功能和全面的服务合同，以加强与医院的关係并创造可预测的收入来源。同时，专注于一次性产品、光学技术和数位分析的新兴参与企业正利用密集的研发投入和灵活的商业化策略，争取在特定应用场景和临床环境中获得支援。

为行业领导者提供切实可行的建议，以增强韧性、加快临床部署，并使产品和商业策略与不断变化的医疗保健提供者的优先事项保持一致。

产业领导者应采取一系列协作行动，以平衡短期韧性和长期竞争力。首先，应实现生产和采购多元化，以降低关税风险和供应波动，同时评估近岸外包和区域组装方案，从而缩短前置作业时间。同时，应优先考虑减少对关税敏感部件依赖的产品设计，并简化消毒流程，以满足日益增长的感染控制要求。

采用严谨的混合调查方法，结合临床医生和采购负责人的原始资讯、二手证据以及专家检验，得出可靠的研究结果。

本执行摘要的研究采用混合方法，整合了质性一手访谈、二手文献和结构化检验，以得出可靠的结论。一级资讯来源包括透过咨询临床专家、采购经理和医疗设备工程师收集的关于可用性、再处理负担和临床证据要求等方面的实地观点。二手分析则利用监管指导文件、临床试验註册资讯和同行评审文献来检验技术声明并分析监管趋势。

简洁的结论强调了以证据为基础的创新、供应链韧性和综合商业策略对于实现长期成长的必要性。

总之，内视镜治疗设备的格局正受到临床、技术和商业性因素的共同影响而重塑，这要求企业具备策略灵活性。影像技术和设备设计的进步提高了诊断准确性和治疗能力，而一次性平台和不断变化的灭菌要求正在改变采购和服务模式。贸易趋势和关税措施正在加速供应链多元化，并促使人们重新关注区域製造策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜治疗设备市场：依产品类型划分

  • 胶囊内视镜
  • 软式内视镜
  • 硬式内视镜

第九章 内视镜治疗设备市场：依技术划分

  • 三维成像
  • 高清成像
  • 窄频成像

第十章 内视镜治疗设备市场：依应用领域划分

  • 关节镜
  • 胃肠内视镜检查
    • 下消化道内视镜检查
    • 上消化道内视镜检查
  • 肺内视镜检查
  • 泌尿系统视镜检查
    • 膀胱镜检查
    • 输尿管镜检查

第十一章 内视镜治疗设备市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十二章 内视镜治疗设备市场：依通路划分

  • 直接竞标
  • 批发商

第十三章 内视镜治疗设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 内视镜治疗设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 内视镜治疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国内视镜治疗设备市场

第十七章：中国内视镜治疗器材市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • ERBE Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Globus Medical, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • Olympus Corporation
  • Otsuka Holdings Co., Ltd.
  • Pentax Medical Company, Ltd.
  • Renishaw PLC
Product Code: MRR-1A1A064C0676

The Endotherapy Devices Market was valued at USD 5.80 billion in 2025 and is projected to grow to USD 6.20 billion in 2026, with a CAGR of 7.96%, reaching USD 9.92 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.80 billion
Estimated Year [2026] USD 6.20 billion
Forecast Year [2032] USD 9.92 billion
CAGR (%) 7.96%

Comprehensive introduction to endotherapy devices highlighting clinical evolution, technology convergence, safety priorities, and commercial drivers reshaping adoption

Endotherapy devices have entered a phase of rapid clinical and commercial maturation driven by convergent advances in optics, materials science, and procedural practice. Clinicians increasingly demand tools that deliver superior visualization while reducing procedural risk and throughput time, and manufacturers are responding with innovations spanning single-use platforms, enhanced imaging modalities, and modular service offerings. As a result, procurement teams and clinical leaders are reconsidering long-standing assumptions around device lifecycle, cost of ownership, and infection control.

Moreover, the clinical imperative to improve patient outcomes and procedural efficiency is aligning with broader systemic priorities, including supply chain reliability and regulatory scrutiny. This alignment has elevated device sterility, ease of reprocessing, and interoperability with digital systems as core selection criteria. Consequently, companies that can demonstrate robust clinical evidence, streamlined logistics, and predictable total cost profiles are increasingly favored by hospital systems and ambulatory centers.

Taken together, these forces have reshaped competitive dynamics and created new entry points for technology providers. Strategic clarity around clinical value propositions, evidence generation, and channel engagement will determine which firms convert innovation into widespread adoption and sustained commercial success.

Analysis of transformative shifts driving the endotherapy landscape including single-use adoption, imaging advances, AI enablement, and regulatory inflection points

The landscape of endotherapy devices is changing in fundamental ways that extend beyond incremental product upgrades. Single-use flexible and rigid devices are transforming procurement and infection control paradigms, reducing reprocessing burdens and shifting service economics. At the same time, imaging innovations such as high-definition and narrow band imaging have raised the clinical bar for lesion detection and therapeutic precision, prompting clinicians to prefer devices that integrate advanced optics and improved illumination.

Concurrently, digital enablement through image analytics and early-stage artificial intelligence is beginning to influence workflow optimization and diagnostic consistency. Robotics and enhanced endoscope maneuverability are expanding procedural capabilities, reducing operator fatigue and broadening the range of minimally invasive interventions. These technological shifts are complemented by operational adjustments: health systems are consolidating supplier relationships, emphasizing service contracts and bundled procurement, while regulatory agencies are tightening guidance around device reprocessing and environmental safety.

As a result, companies must pivot from product-centric roadmaps to solutions that combine clinical evidence, digital integration, and lifecycle services. Those that successfully align innovation investments with evolving provider needs, reimbursement realities, and regulatory expectations will secure advantaged positions in an increasingly outcomes-driven market.

Assessment of the cumulative impact of United States tariff measures introduced in 2025 on supply chains, procurement decisions, and product design incentives

The cumulative effects of tariff measures introduced in 2025 have created immediate and second-order consequences across the endotherapy device ecosystem. In the near term, increased import duties have raised landed costs for devices and key components, prompting procurement teams to re-evaluate supplier portfolios and consider alternative sourcing strategies. This pressure has accelerated interest in local manufacturing and nearshoring initiatives, as stakeholders prioritize supply chain resilience and predictable lead times.

Over time, these trade measures have influenced product-level decisions. Manufacturers with geographically diversified production footprints have been better positioned to absorb cost pressure and maintain contractual pricing stability, whereas firms reliant on single-region supply have had to either renegotiate commercial terms or pass increased costs downstream. For healthcare providers, the tariff environment has heightened scrutiny of total ownership costs, sterilization expenditures, and the comparative economics of reusable versus single-use devices.

Furthermore, tariffs have catalyzed strategic responses beyond pricing. Some companies have intensified partnerships with distributors and local assemblers to mitigate duties, while others have increased investment in product designs that rely less on tariff-exposed components. In parallel, procurement organizations have leveraged longer-term agreements and volume commitments to secure price certainty. Ultimately, the tariff-driven adjustments are accelerating structural shifts that were already underway: a move toward supply chain diversification, heightened emphasis on domestic capabilities, and a renewed focus on demonstrable clinical and economic value.

Strategic segmentation insights explaining how product, application, end user, channel, and imaging technology distinctions influence clinical priorities and commercialization strategies

Insight into segmentation reveals how product, application, end user, distribution, and technology distinctions shape strategic priorities and innovation pathways. Based on product type the landscape includes capsule endoscopes alongside both flexible endoscopes and rigid endoscopes, with flexible models further differentiated into reusable flexible endoscopes and single-use flexible endoscopes while rigid endoscopes are examined across reusable rigid endoscopes and single-use rigid endoscopes. This product-level granularity influences decisions around sterilization protocols, device ergonomics, and service models, and it determines which firms invest in disposability versus durable instrumentation.

Based on application the field spans arthroscopy, gastrointestinal endoscopy, pulmonary endoscopy, and urological endoscopy, with gastrointestinal procedures further divided into lower and upper gastrointestinal endoscopy and urological procedures separated into cystoscopy and ureteroscopy. Each application segment imposes distinct clinical requirements, imaging preferences, and accessory ecosystems, thereby guiding product feature priorities and clinical evidence needs. Based on end user healthcare delivery settings range from ambulatory surgical centers to clinics and hospitals, and these settings exhibit different purchasing cycles, sterilization resources, and procedural volumes that affect device selection and service expectations.

Based on distribution channel procurement occurs through direct tender arrangements as well as distributor wholesaler networks, and channel choice impacts commercial models, service delivery, and aftermarket support. Based on technology offerings encompass 3D imaging, high definition imaging, and narrow band imaging, and these technological pathways drive differentiation in lesion detection capability, therapeutic accuracy, and integration with image analytics. Understanding the interplay among these segmentation axes is essential for tailoring product portfolios, targeting clinical partnerships, and aligning commercialization strategies with end-user workflows.

Key regional insights into how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape adoption dynamics, regulatory interactions, and manufacturing strategies

Regional dynamics continue to dictate adoption patterns, regulatory interactions, and manufacturing strategies across the global endotherapy environment. In the Americas procurement sophistication and a strong emphasis on infection control have propelled interest in single-use devices and advanced imaging tools, while regional innovation hubs support clinical trials and post-market evidence generation. Meanwhile, reimbursement frameworks and hospital consolidation trends influence how quickly new technologies can be integrated into procedural pathways, with large health systems serving as early adopters for technologies that demonstrably improve outcomes.

In Europe, Middle East & Africa regulatory harmonization efforts and diverse payer landscapes create a mosaic of adoption timelines and cost sensitivities. In several European markets, centralized procurement and robust reprocessing infrastructures continue to support reusable device models, yet infection control imperatives and lifecycle cost scrutiny are increasing demand for single-use alternatives in specific clinical settings. Emerging markets within this region present growth opportunities linked to expanding procedural access and investments in diagnostic capacity, though pricing and infrastructure constraints require tailored go-to-market approaches.

Across Asia-Pacific a combination of rapid procedural uptake, growing domestic manufacturing capabilities, and policy emphasis on healthcare modernization has encouraged both innovation and competitive pressure. Local manufacturers and global firms operating in the region must navigate a range of regulatory regimes, local content expectations, and clinical training needs. Taken together, geographic distinctions underscore the necessity of region-specific commercialization playbooks that account for regulatory nuance, procurement mechanics, and clinical adoption drivers.

Key company-level insights into how incumbents and new entrants use portfolio expansion, partnerships, and evidence generation to secure clinical adoption and commercial advantage

Competitive dynamics among leading companies are being redefined by the interplay of innovation, service economics, and strategic partnerships. Established device manufacturers are expanding their portfolios to include single-use options, enhanced imaging capabilities, and bundled service agreements to lock in hospital relationships and create predictable revenue streams. At the same time, new entrants specializing in disposables, optics, or digital analytics are leveraging focused R&D and nimble commercialization to capture niche use cases and clinical champions.

Collaboration between device makers and clinical research organizations is becoming more strategic, with joint programs designed to produce robust evidence that supports adoption in procedural specialties. Similarly, alliances with distributors and local service providers are essential for scaling after-sales support and reprocessing alternatives in regions where centralized sterilization remains prevalent. Mergers, acquisitions, and licensing deals are playing a role in consolidating technology stacks and accelerating time-to-market for advanced imaging and single-use platforms.

Ultimately, companies that align R&D investments with clear clinical use cases, invest in training and service delivery, and create flexible commercial models will be positioned to win. Strategic clarity around aftermarket services, consumable economics, and digital integration will determine which players sustain profitable growth and long-term provider partnerships.

Actionable recommendations for industry leaders to enhance resilience, accelerate clinical adoption, and align product and commercial strategies with evolving provider priorities

Industry leaders should pursue a coordinated set of actions that balance near-term resilience with long-term competitiveness. First, diversify manufacturing and sourcing to reduce tariff exposure and supply volatility while also evaluating nearshoring or regional assembly options that improve lead times. In parallel, prioritize product designs that reduce reliance on tariff-sensitive components and that simplify sterilization to meet heightened infection control expectations.

Second, accelerate development of single-use offerings alongside durable platforms and create clear clinical and economic narratives that help providers assess total ownership and safety trade-offs. Evidence generation must be proactive: invest in pragmatic clinical studies and real-world data initiatives that demonstrate improvements in procedural outcomes, throughput, and cost-efficiency. Third, strengthen channel and service models by forming deeper partnerships with distributors and health systems, offering bundled maintenance or consumable agreements that create predictable revenue and improve customer retention.

Finally, engage early with regulators and payers to clarify clinical benefit thresholds and reimbursement pathways, and embed digital capabilities such as enhanced imaging interoperability and analytics to differentiate products. By integrating these strategic moves, organizations can transform short-term challenges into durable competitive advantages and align innovation with provider and patient needs.

Rigorous mixed-methods research methodology combining primary clinician and procurement inputs with secondary evidence synthesis and expert validation for defensible insights

The research underpinning this executive summary employs a mixed-methods approach that integrates primary qualitative interviews, secondary literature synthesis, and structured triangulation to ensure robust conclusions. Primary inputs included consultations with clinical specialists, procurement leaders, and device engineers to capture frontline perspectives on usability, reprocessing burdens, and clinical evidence requirements. Secondary analysis drew on regulatory guidance documents, clinical trial registries, and peer-reviewed literature to validate technological claims and map regulatory trends.

Data triangulation was applied across multiple sources to reconcile differing perspectives and to highlight consensus themes, such as the growing importance of single-use platforms and advanced imaging. Expert panels were convened to test preliminary findings and to identify risk factors related to supply chain disruption, tariff exposure, and adoption barriers. Where applicable, device lifecycle and procurement process frameworks were used to standardize comparisons across product types and end-user settings.

Limitations of the methodology include variability in publicly available clinical evidence across device categories and the dynamic nature of trade and regulatory environments. To mitigate these constraints, the study emphasizes qualitative validation, cross-regional comparisons, and scenario-based implications rather than quantitative forecasts, thereby providing actionable and defensible insights for strategic decision-making.

Concise conclusion emphasizing the need for evidence-driven innovation, supply chain resilience, and integrated commercial strategies to realize long-term growth

In conclusion, the endotherapy device landscape is being reshaped by a confluence of clinical, technological, and commercial forces that demand strategic agility. Advances in imaging and device design are enhancing diagnostic precision and therapeutic capability, while single-use platforms and evolving sterilization imperatives are altering procurement and service models. Trade dynamics and tariff measures have accelerated supply chain diversification and prompted renewed attention to regional manufacturing strategies.

Providers and manufacturers alike must prioritize evidence generation, supply chain resilience, and differentiated service models to thrive in this environment. By aligning product development with demonstrable clinical value and by engaging proactively with payers and regulators, organizations can navigate current headwinds and capitalize on emerging opportunities. The path forward requires integrated strategies that combine technological innovation, commercial flexibility, and deep clinical partnership to ensure that devices deliver measurable improvements in patient care and operational performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endotherapy Devices Market, by Product Type

  • 8.1. Capsule Endoscopes
  • 8.2. Flexible Endoscopes
  • 8.3. Rigid Endoscopes

9. Endotherapy Devices Market, by Technology

  • 9.1. 3D Imaging
  • 9.2. High Definition Imaging
  • 9.3. Narrow Band Imaging

10. Endotherapy Devices Market, by Application

  • 10.1. Arthroscopy
  • 10.2. Gastrointestinal Endoscopy
    • 10.2.1. Lower Gastrointestinal Endoscopy
    • 10.2.2. Upper Gastrointestinal Endoscopy
  • 10.3. Pulmonary Endoscopy
  • 10.4. Urological Endoscopy
    • 10.4.1. Cystoscopy
    • 10.4.2. Ureteroscopy

11. Endotherapy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Endotherapy Devices Market, by Distribution Channel

  • 12.1. Direct Tender
  • 12.2. Distributor Wholesaler

13. Endotherapy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endotherapy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endotherapy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endotherapy Devices Market

17. China Endotherapy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Boston Scientific Corporation
  • 18.6. CONMED Corporation
  • 18.7. Cook Medical LLC
  • 18.8. ERBE Elektromedizin GmbH
  • 18.9. Fujifilm Holdings Corporation
  • 18.10. Globus Medical, Inc.
  • 18.11. Intuitive Surgical, Inc.
  • 18.12. Johnson & Johnson
  • 18.13. Karl Storz SE & Co. KG
  • 18.14. Medtronic PLC
  • 18.15. Olympus Corporation
  • 18.16. Otsuka Holdings Co., Ltd.
  • 18.17. Pentax Medical Company, Ltd.
  • 18.18. Renishaw PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOTHERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOTHERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HIGH DEFINITION IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HIGH DEFINITION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HIGH DEFINITION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PULMONARY ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PULMONARY ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PULMONARY ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTOR WHOLESALER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTOR WHOLESALER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTOR WHOLESALER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)